2020-11-21 15:32:00| Fool.com Headlines
The choice between these biotechs isn't an easy one.
2020-11-17 12:36:00| Fool.com Headlines
Can this small-cap coronavirus vaccine developer make investors rich?
2020-11-16 17:34:00| Fool.com Headlines
Investors are worried that Moderna's good news could be bad news for these coronavirus vaccine leaders.
2020-11-16 16:00:00| Fool.com Headlines
Novavax and Sorrento Therapeutics have been on a sharp downward trajectory.
Sites :